Today’s Top Three in Pharma 021909 posted on February 19, 2009Teva aggressively seeking to "genericize" Merck's Singulair, Amgen's Neupogen. Warren Buffet pulling back from pharma investments that contain 2 letters (P&G, J&J). GSK's nausea drug Zofran …Continue Reading about Today’s Top Three in Pharma 021909 →